Cargando…

Circulatory and prostatic tissue lipidomic profiles shifts after high-dose atorvastatin use in men with prostate cancer

Prostate cancer patients using cholesterol-lowering statins have 30% lower risk of prostate cancer death compared to non-users. The effect is attributed to the inhibition of the mevalonate pathway in prostate cancer cells. Moreover, statin use causes lipoprotein metabolism changes in the serum. Stat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raittinen, Paavo, Niemistö, Kati, Pennanen, Erika, Syvälä, Heimo, Auriola, Seppo, Riikonen, Jarno, Lehtimäki, Terho, Ilmonen, Pauliina, Murtola, Teemu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374714/ https://www.ncbi.nlm.nih.gov/pubmed/32694638 http://dx.doi.org/10.1038/s41598-020-68868-5

Ejemplares similares

Atorvastatin induces adrenal androgen downshift in men with prostate cancer: A post Hoc analysis of a pilot adaptive Randomised clinical trial
por: Raittinen, Paavo V.H., et al.
Publicado: (2021)

Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol
por: Siltari, Aino, et al.
Publicado: (2022)

The Importance of LDL and Cholesterol Metabolism for Prostate Epithelial Cell Growth
por: Murtola, Teemu J., et al.
Publicado: (2012)

Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation
por: Nätkin, Reetta, et al.
Publicado: (2023)

Role of Lipids and Lipid Metabolism in Prostate Cancer Progression and the Tumor’s Immune Environment
por: Siltari, Aino, et al.
Publicado: (2022)

Human Prostate Tissue MicroRNAs and Their Predicted Target Pathways Linked to Prostate Cancer Risk Factors
por: Enwald, Max, et al.
Publicado: (2021)

Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users. A population-based cohort study
por: Peltomaa, A. I., et al.
Publicado: (2021)

Pharmacoepidemiological Evaluation in Prostate Cancer—Common Pitfalls and How to Avoid Them
por: Siltari, Aino, et al.
Publicado: (2021)

Length of prostate biopsies is not necessarily compromised by pooling multiple cores in one paraffin block: an observational study
por: Tolonen, Teemu T, et al.
Publicado: (2015)

Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer
por: Kaapu, Kalle J, et al.
Publicado: (2016)

Prostate cancer incidence in men with prostate‐specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer
por: Ola, Idris Olasunmbo, et al.
Publicado: (2022)

Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer
por: Kinnunen, Pete T. T., et al.
Publicado: (2017)

Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer
por: Murtola, Teemu J., et al.
Publicado: (2018)

Prostate Cancer–specific Survival After Radical Prostatectomy Is Improved Among Metformin Users but Not Among Other Antidiabetic Drug Users
por: Joentausta, Roni M., et al.
Publicado: (2021)

Antihypertensive drug use and prostate cancer-specific mortality in Finnish men
por: Siltari, Aino, et al.
Publicado: (2020)

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine
por: Nurminen, Anssi, et al.
Publicado: (2023)

Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial
por: Veitonmäki, Thea, et al.
Publicado: (2016)

Lipidomics as a Diagnostic Tool for Prostate Cancer
por: Buszewska-Forajta, Magdalena, et al.
Publicado: (2021)

Including Information on Overdiagnosis in Shared Decision Making: A Review of Prostate Cancer Screening Decision Aids
por: Pathirana, Thanya I., et al.
Publicado: (2022)

Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines
por: Brzozowski, Joshua S., et al.
Publicado: (2018)

Anti-epileptic drugs and prostate cancer-specific mortality compared to non-users of anti-epileptic drugs in the Finnish Randomized Study of Screening for Prostate Cancer
por: Salminen, Jukka K., et al.
Publicado: (2022)

Lipidome‐ and Genome‐Wide Study to Understand Sex Differences in Circulatory Lipids
por: Tabassum, Rubina, et al.
Publicado: (2022)

Identification of Plasma Lipid Biomarkers for Prostate Cancer by Lipidomics and Bioinformatics
por: Zhou, Xinchun, et al.
Publicado: (2012)

Comparative Metabolomic and Lipidomic Analysis of Phenotype Stratified Prostate Cells
por: Burch, Tanya C., et al.
Publicado: (2015)

Uncovering the complex genetic architecture of human plasma lipidome using machine learning methods
por: Lehtimäki, Miikael, et al.
Publicado: (2023)

Virus encoded circulatory miRNAs for early detection of prostate cancer
por: Kim, Jayoung, et al.
Publicado: (2015)

Circulatory MIC-1 as a Determinant of Prostate Cancer Racial Disparity
por: Karan, Dev, et al.
Publicado: (2020)

l-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia
por: Huttunen, Johanna, et al.
Publicado: (2019)

Phase II proof‐of‐concept study of atorvastatin in castration‐resistant prostate cancer
por: Rushworth, Linda K., et al.
Publicado: (2022)

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial
por: Veitonmäki, T, et al.
Publicado: (2014)

Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
por: Murtola, T J, et al.
Publicado: (2009)

Identification of lipidomic profiles associated with drug-resistant prostate cancer cells
por: Ingram, Lishann M., et al.
Publicado: (2021)

Unravelling Prostate Cancer Heterogeneity Using Spatial Approaches to Lipidomics and Transcriptomics
por: Mutuku, Shadrack M., et al.
Publicado: (2022)

Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-analysis
por: Riikonen, Jarno M., et al.
Publicado: (2019)

Tumor margins that lead to reoperation in breast cancer: A retrospective register study of 4,489 patients
por: Lepomäki, Maiju, et al.
Publicado: (2021)

AB158. Atorvastatin induces autophagic cell death in prostate cancer cells in vitro
por: He, Zhenhua, et al.
Publicado: (2016)

On Exploring Hidden Structures Behind Cervical Cancer Incidence
por: Lietzén, Niko, et al.
Publicado: (2018)

Fast tensorial JADE
por: Virta, Joni, et al.
Publicado: (2020)

SUN-LB002 CYP11A1 Inhibition as a Therapeutic Approach for the Treatment of Castration Resistant Prostate Cancer
por: Oksala, Riikka, et al.
Publicado: (2019)

Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases
por: Sattari, Mina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4qg8cimpt0sqjqbh0da4hj7f42